The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) says the 23andMe spit test, which is designed to give details about a person’s health risks based on their DNA, can be used with caution.
But critics say it may not be accurate enough to base health decisions on.
The company, California-based 23andMe, stands by its test.
Backed by Google, the firm offered U.S. customers details of health risks based on gene variants they carry.
But in November 2013, the U.S. Food and Drug Administration (FDA) banned the company from marketing its service in the U.S., claiming 23andMe had failed to provide adequate information to support the claims it made about results.
Share this article
A month later, the company stopped offering genetic tests related to health.
An MHRA spokesperson said it regulated such tests in the UK to make sure they met minimum standards.
“People who use these products should ensure that they are CE marked and remember that no test is 100% reliable so think carefully before using personal genome services.
Read full, original article: Controversial DNA test comes to the UK
